NCT05758493: An ongoing trial by Oregon Health and Science University
This trial is ongoing. It must report results 2 years, 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05758493 |
|---|---|
| Title | Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 10, 2023 |
| Completion date | Dec. 10, 2027 |
| Required reporting date | Dec. 9, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |